AHRR rs2292596: Understanding Smoking-Related Epigenetic Markers
The rs2292596 variant is located within the AHRR gene, which plays a critical role in regulating the body's response to environmental toxins. Research indicates that DNA methylation levels at this locus are strongly associated with smoking history, serving as a reliable epigenetic biomarker for exposure.
What each genotype means
Typical sleep and metabolic profile
You carry two copies of the common C allele at rs2292596 in the AHRR gene. Large-scale genome-wide association studies link this genotype with baseline population risk for self-reported insomnia symptoms and typical AHRR-mediated aryl-hydrocarbon receptor signaling. Evidence for any direct health outcome remains limited, and variations in lifestyle factors like smoking and sleep hygiene play a much larger role.
Carried by approximately 50% to 60% of individuals of European ancestry and roughly 35% to 45% in East Asian populations.
Slightly altered sleep trait predisposition
You have one copy of the C allele and one copy of the minor G allele. In genetic association studies, the G allele has shown small, modest statistical correlations with insomnia traits and differential susceptibility in xenobiotic receptor pathways. Because effect sizes are very subtle and research evidence is limited, this result has minimal standalone clinical significance.
Carried by roughly 35% to 45% of individuals across European and East Asian cohorts.
Minor allele homozygote profile
You carry two copies of the minor G allele (historically referred to as the Pro185Ala or Ala-encoding variant). Studies have evaluated this genotype for subtle associations with sleep duration and insomnia symptoms, as well as gene-environment interactions involving smoking exposure and aryl-hydrocarbon pathway activity. Findings are limited and show only tiny statistical effects, meaning this profile should not be taken as an indicator of any sleep or medical disorder.
Present in about 5% to 10% of European cohorts and up to 15% to 20% in some East Asian populations.
What is rs2292596 and the AHRR Gene?
The rs2292596 variant is a single nucleotide polymorphism (SNP) situated within the AHRR gene, which encodes the aryl hydrocarbon receptor repressor. This gene acts as a negative feedback regulator of the aryl hydrocarbon receptor (AHR), a protein that mediates the body's response to various environmental pollutants, including those found in cigarette smoke. By competing with AHR for binding sites, AHRR helps modulate the expression of genes involved in detoxification processes. While the SNP itself is a genetic sequence variation, the primary scientific interest in this region lies in its epigenetic state. Specifically, the methylation status of CpG sites within the AHRR gene is highly sensitive to environmental factors, particularly cigarette smoke, making it a focal point for researchers studying how lifestyle choices leave lasting marks on our DNA.
The Link Between AHRR and Smoking
Extensive research has established that smoking is associated with significant changes in DNA methylation at the AHRR locus. Studies consistently show that current smokers exhibit lower levels of methylation (hypomethylation) at specific sites within this gene compared to never smokers. This relationship is so robust that AHRR methylation is often used as a master predictor of smoke exposure in epigenetic studies. The degree of demethylation is frequently correlated with the intensity and duration of smoking. Importantly, this process appears to be partially reversible; individuals who quit smoking often show a recovery in methylation levels over time, suggesting that the epigenetic signature of smoking is not necessarily permanent. This makes the AHRR locus a valuable tool for monitoring the biological impact of smoking cessation and long-term exposure.
Evidence Strength and Population Variability
The association between AHRR methylation and smoking is considered strong and has been replicated across diverse populations, including European, Asian, and African American cohorts. However, researchers note that population-specific differences in baseline methylation levels exist, and interactions between smoking status and ancestry can influence the observed epigenetic patterns. While the link between smoking and AHRR methylation is well-documented, the specific role of the rs2292596 genotype in driving these changes remains a subject of ongoing investigation. Some studies suggest that underlying genetic vulnerability may act as a confounder in epigenetic research, meaning that an individual's inherited DNA sequence might influence how their body responds to environmental stressors. Because the evidence regarding the direct functional impact of the rs2292596 SNP itself is limited, it is best viewed as a marker within a complex regulatory landscape.
Practical Considerations for Consumers
It is important to understand that information regarding genetic variants like rs2292596 is for educational purposes and does not constitute medical advice. This variant is not a diagnostic tool for disease, nor can it predict an individual's specific health outcomes. While epigenetic markers like those at the AHRR gene provide fascinating insights into how lifestyle choices like smoking affect our biology, they should not be used to make personal health decisions without consulting a qualified healthcare professional. If you are concerned about the health impacts of smoking or your personal risk factors, please speak with your doctor. They can provide guidance based on your full medical history and current clinical guidelines. Never use genetic or epigenetic data to self-diagnose or alter any prescribed treatment plans or lifestyle interventions.
How common is this variant?
The rs2292596 variant is a common SNP found globally, with its specific genotype frequencies varying slightly across different ancestral populations.
Frequently asked questions
Is AHRR methylation a test for lung cancer?
No, AHRR methylation is a biomarker for smoking exposure, not a diagnostic test for lung cancer. While smoking is a major risk factor for lung disease, this epigenetic marker reflects your history of smoke exposure rather than the presence of a specific disease.
Can I reverse the methylation changes in my AHRR gene?
Research suggests that AHRR methylation levels can recover after smoking cessation. Former smokers often show intermediate methylation profiles compared to current and never smokers, indicating that the body may partially reverse these epigenetic changes after quitting.
Does my genotype for rs2292596 determine if I will get addicted to smoking?
There is no evidence that the rs2292596 genotype alone determines smoking addiction. Addiction is a complex trait influenced by a combination of genetic, environmental, and behavioral factors.
Should I get tested for this variant?
There is no clinical utility in testing for the rs2292596 variant for general health management. If you have concerns about your health or smoking history, it is best to discuss them with your primary care physician.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2292596?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29